Published in Infect Immun on September 01, 1999
Burkholderia xenovorans LB400 harbors a multi-replicon, 9.73-Mbp genome shaped for versatility. Proc Natl Acad Sci U S A (2006) 3.07
The Aspergillus fumigatus siderophore biosynthetic gene sidA, encoding L-ornithine N5-oxygenase, is required for virulence. Infect Immun (2005) 1.84
Role of siderophore biosynthesis in virulence of Staphylococcus aureus: identification and characterization of genes involved in production of a siderophore. Infect Immun (2004) 1.69
The Burkholderia cepacia epidemic strain marker is part of a novel genomic island encoding both virulence and metabolism-associated genes in Burkholderia cenocepacia. Infect Immun (2004) 1.60
Identification of Burkholderia cenocepacia genes required for bacterial survival in vivo. Infect Immun (2004) 1.57
Regulation of ornibactin biosynthesis and N-acyl-L-homoserine lactone production by CepR in Burkholderia cepacia. J Bacteriol (2001) 1.49
A genetic locus required for iron acquisition in Mycobacterium tuberculosis. Proc Natl Acad Sci U S A (2006) 1.49
Comparative analysis of plant and animal models for characterization of Burkholderia cepacia virulence. Infect Immun (2003) 1.41
Involvement of a plasmid-encoded type IV secretion system in the plant tissue watersoaking phenotype of Burkholderia cenocepacia. J Bacteriol (2004) 1.40
Characterization of the cciIR quorum-sensing system in Burkholderia cenocepacia. Infect Immun (2005) 1.35
Molecular basis of rare aminoglycoside susceptibility and pathogenesis of Burkholderia pseudomallei clinical isolates from Thailand. PLoS Negl Trop Dis (2009) 1.34
Identification of specific and universal virulence factors in Burkholderia cenocepacia strains by using multiple infection hosts. Infect Immun (2009) 1.27
Molecular and physical characterization of Burkholderia mallei O antigens. J Bacteriol (2002) 1.26
Burkholderia cenocepacia creates an intramacrophage replication niche in zebrafish embryos, followed by bacterial dissemination and establishment of systemic infection. Infect Immun (2010) 1.25
A decade of Burkholderia cenocepacia virulence determinant research. Infect Immun (2010) 1.22
Attenuated virulence of a Burkholderia cepacia type III secretion mutant in a murine model of infection. Infect Immun (2003) 1.15
Enzymatic tailoring of ornithine in the biosynthesis of the Rhizobium cyclic trihydroxamate siderophore vicibactin. J Am Chem Soc (2009) 1.15
Burkholderia spp. alter Pseudomonas aeruginosa physiology through iron sequestration. J Bacteriol (2004) 1.13
Importance of the ornibactin and pyochelin siderophore transport systems in Burkholderia cenocepacia lung infections. Infect Immun (2004) 1.11
Differential persistence among genomovars of the Burkholderia cepacia complex in a murine model of pulmonary infection. Infect Immun (2002) 1.07
Genetic and transcriptional analysis of the siderophore malleobactin biosynthesis and transport genes in the human pathogen Burkholderia pseudomallei K96243. J Bacteriol (2006) 1.06
The ornibactin biosynthesis and transport genes of Burkholderia cenocepacia are regulated by an extracytoplasmic function sigma factor which is a part of the Fur regulon. J Bacteriol (2006) 1.02
ATP-binding cassette systems in Burkholderia pseudomallei and Burkholderia mallei. BMC Genomics (2007) 1.00
Identification of a siderophore receptor required for ferric ornibactin uptake in Burkholderia cepacia. Infect Immun (2000) 0.99
Identification of Burkholderia cenocepacia strain H111 virulence factors using nonmammalian infection hosts. Infect Immun (2012) 0.97
Heterologous expression, purification, and characterization of an l-ornithine N(5)-hydroxylase involved in pyoverdine siderophore biosynthesis in Pseudomonas aeruginosa. J Bacteriol (2006) 0.97
Localization and characterization of two novel genes encoding stereospecific dioxygenases catalyzing 2(2,4-dichlorophenoxy)propionate cleavage in Delftia acidovorans MC1. Appl Environ Microbiol (2004) 0.96
Use of suppression-subtractive hybridization to identify genes in the Burkholderia cepacia complex that are unique to Burkholderia cenocepacia. J Bacteriol (2005) 0.96
Functional analysis of Burkholderia cepacia genes bceD and bceF, encoding a phosphotyrosine phosphatase and a tyrosine autokinase, respectively: role in exopolysaccharide biosynthesis and biofilm formation. Appl Environ Microbiol (2006) 0.95
Experimental adaptation of Burkholderia cenocepacia to onion medium reduces host range. Appl Environ Microbiol (2010) 0.92
Exploring the metabolic network of the epidemic pathogen Burkholderia cenocepacia J2315 via genome-scale reconstruction. BMC Syst Biol (2011) 0.91
Identification of potential therapeutic targets for Burkholderia cenocepacia by comparative transcriptomics. PLoS One (2010) 0.89
Site-specific rate constants for iron acquisition from transferrin by the Aspergillus fumigatus siderophores N',N'',N'''-triacetylfusarinine C and ferricrocin. J Biol Inorg Chem (2005) 0.89
A BCAM0223 mutant of Burkholderia cenocepacia is deficient in hemagglutination, serum resistance, adhesion to epithelial cells and virulence. PLoS One (2012) 0.88
Burkholderia pseudomallei known siderophores and hemin uptake are dispensable for lethal murine melioidosis. PLoS Negl Trop Dis (2012) 0.88
Transcriptional and posttranscriptional control of cable pilus gene expression in Burkholderia cenocepacia. J Bacteriol (2004) 0.86
Burkholderia cenocepacia differential gene expression during host-pathogen interactions and adaptation to the host environment. Front Cell Infect Microbiol (2011) 0.85
Pseudobactin biogenesis in the plant growth-promoting rhizobacterium Pseudomonas strain B10: identification and functional analysis of the L-ornithine N(5)-oxygenase (psbA) gene. J Bacteriol (2000) 0.84
Mechanistic and structural studies of the N-hydroxylating flavoprotein monooxygenases. Bioorg Chem (2011) 0.83
Persistence of Burkholderia multivorans within the pulmonary macrophage in the murine lung. Infect Immun (2004) 0.82
Role of lipase in Burkholderia cepacia complex (Bcc) invasion of lung epithelial cells. Eur J Clin Microbiol Infect Dis (2007) 0.82
Comparative transcriptomic analysis of the Burkholderia cepacia tyrosine kinase bceF mutant reveals a role in tolerance to stress, biofilm formation, and virulence. Appl Environ Microbiol (2013) 0.81
Global changes in gene expression by the opportunistic pathogen Burkholderia cenocepacia in response to internalization by murine macrophages. BMC Genomics (2012) 0.80
Identification of sodium chloride-regulated genes in Burkholderia cenocepacia. Curr Microbiol (2008) 0.80
Iron acquisition in the cystic fibrosis lung and potential for novel therapeutic strategies. Microbiology (2015) 0.79
Burkholderia phytofirmans Inoculation-Induced Changes on the Shoot Cell Anatomy and Iron Accumulation Reveal Novel Components of Arabidopsis-Endophyte Interaction that Can Benefit Downstream Biomass Deconstruction. Front Plant Sci (2016) 0.79
Members of the genus Burkholderia: good and bad guys. F1000Res (2016) 0.76
Genetic and Functional Analysis of the Biosynthesis of a Non-Ribosomal Peptide Siderophore in Burkholderia xenovorans LB400. PLoS One (2016) 0.76
Extracellular glutathione decreases the ability of Burkholderia cenocepacia to penetrate into epithelial cells and to induce an inflammatory response. PLoS One (2012) 0.76
Discovery of new diketopiperazines inhibiting Burkholderia cenocepacia quorum sensing in vitro and in vivo. Sci Rep (2016) 0.76
Sequencing of the Pseudomonas aeruginosa and Burkholderia cepacia genomes and their applications in relation to cystic fibrosis. J R Soc Med (2003) 0.75
The Siderophore Product Ornibactin Is Required for the Bactericidal Activity of Burkholderia contaminans MS14. Appl Environ Microbiol (2017) 0.75
Understanding the Pathogenicity of Burkholderia contaminans, an Emerging Pathogen in Cystic Fibrosis. PLoS One (2016) 0.75
Heteroatom-Heteroatom Bond Formation in Natural Product Biosynthesis. Chem Rev (2017) 0.75
The regulator LdhR and the d-lactate dehydrogenase LdhA of Burkholderia multivorans play a role in carbon overflow and in planktonic cellular aggregates formation. Appl Environ Microbiol (2017) 0.75
HOST IMMUNE RECOGNITION OF THE EPIDEMIC CYSTIC FIBROSIS PATHOGEN BURKHOLDERIA DOLOSA. Infect Immun (2017) 0.75
Replication of an origin-containing derivative of plasmid RK2 dependent on a plasmid function provided in trans. Proc Natl Acad Sci U S A (1979) 44.75
Universal chemical assay for the detection and determination of siderophores. Anal Biochem (1987) 18.60
Small broad-host-range gentamycin resistance gene cassettes for site-specific insertion and deletion mutagenesis. Biotechniques (1993) 6.06
Escherichia-Pseudomonas shuttle vectors derived from pUC18/19. Gene (1991) 5.90
Occurrence of multiple genomovars of Burkholderia cepacia in cystic fibrosis patients and proposal of Burkholderia multivorans sp. nov. Int J Syst Bacteriol (1997) 5.60
Cloning and expression in Pseudomonas aeruginosa of a gene involved in the production of alginate. J Bacteriol (1984) 4.95
Allelic exchange in Pseudomonas aeruginosa using novel ColE1-type vectors and a family of cassettes containing a portable oriT and the counter-selectable Bacillus subtilis sacB marker. Mol Microbiol (1992) 4.85
A rat model of chronic respiratory infection with Pseudomonas aeruginosa. Am Rev Respir Dis (1979) 4.27
Cosmid vectors for rapid genomic walking, restriction mapping, and gene transfer. Proc Natl Acad Sci U S A (1987) 4.13
Burkholderia cepacia: medical, taxonomic and ecological issues. J Med Microbiol (1996) 4.11
Toxin A-deficient mutants of Pseudomonas aeruginosa PA103: isolation and characterization. Infect Immun (1980) 3.95
Genetics and molecular biology of siderophore-mediated iron transport in bacteria. Microbiol Rev (1989) 3.86
Mutagenesis of Burkholderia pseudomallei with Tn5-OT182: isolation of motility mutants and molecular characterization of the flagellin structural gene. J Bacteriol (1997) 3.60
Applications of network BLAST server. Methods Enzymol (1996) 3.03
Quorum sensing in Burkholderia cepacia: identification of the LuxRI homologs CepRI. J Bacteriol (1999) 2.81
Identification and characterization of a novel DNA marker associated with epidemic Burkholderia cepacia strains recovered from patients with cystic fibrosis. J Clin Microbiol (1997) 2.72
Gene repression by the ferric uptake regulator in Pseudomonas aeruginosa: cycle selection of iron-regulated genes. Proc Natl Acad Sci U S A (1996) 2.71
Rhodotorulic acid, a diketopiperazine dihydroxamic acid with growth-factor activity. I. Isolation and characterization. Biochemistry (1968) 2.65
The 23S ribosomal RNA higher-order structure of Pseudomonas cepacia and other prokaryotes. Eur J Biochem (1989) 2.51
Multiple replicons constituting the genome of Pseudomonas cepacia 17616. J Bacteriol (1994) 2.21
Quantitative methods in the study of pulmonary pathology. Thorax (1962) 2.16
A series of Tn5 variants with various drug-resistance markers and suicide vector for transposon mutagenesis. Gene (1987) 2.01
The role of iron-binding proteins in the survival of pathogenic bacteria. Annu Rev Nutr (1994) 1.93
Production and utilization of pyochelin by clinical isolates of Pseudomonas cepacia. J Clin Microbiol (1986) 1.82
Siderophore production by cystic fibrosis isolates of Burkholderia cepacia. Infect Immun (1998) 1.80
Cloning and characterization of pvdS, a gene required for pyoverdine synthesis in Pseudomonas aeruginosa: PvdS is probably an alternative sigma factor. J Bacteriol (1995) 1.77
Cloning and sequencing of a previously unidentified gene that is involved in the biosynthesis of heme in Escherichia coli. Gene (1995) 1.75
Transport of iron across the outer membrane. Biol Met (1991) 1.74
A physical genome map of the Burkholderia cepacia type strain. Mol Microbiol (1995) 1.73
Broad-host-range cloning and cassette vectors based on the R388 trimethoprim resistance gene. Biotechniques (1996) 1.70
sid1, a gene initiating siderophore biosynthesis in Ustilago maydis: molecular characterization, regulation by iron, and role in phytopathogenicity. Proc Natl Acad Sci U S A (1993) 1.60
Construction and use of a self-cloning promoter probe vector for gram-negative bacteria. Gene (1993) 1.59
Cloning and nucleotide sequence of the pvdA gene encoding the pyoverdin biosynthetic enzyme L-ornithine N5-oxygenase in Pseudomonas aeruginosa. J Bacteriol (1994) 1.58
Simple model for the study of Pseudomonas aeruginosa infections in leukopenic mice. Infect Immun (1983) 1.57
Electrotransformation of Pseudomonas. Methods Mol Biol (1995) 1.47
Iron-regulated salicylate synthesis by Pseudomonas spp. J Gen Microbiol (1993) 1.45
Genetic and physical mapping of genes involved in pyoverdin production in Pseudomonas aeruginosa PAO. J Bacteriol (1995) 1.44
Mapping of mutations in Pseudomonas aeruginosa defective in pyoverdin production. J Bacteriol (1986) 1.43
Nucleotide sequence of pvdD, a pyoverdine biosynthetic gene from Pseudomonas aeruginosa: PvdD has similarity to peptide synthetases. J Bacteriol (1995) 1.42
Iron-regulated transcription of the pvdA gene in Pseudomonas aeruginosa: effect of Fur and PvdS on promoter activity. J Bacteriol (1996) 1.41
Transformation of Salmonella typhimurium with plasmid DNA: differences between rough and smooth strains. J Bacteriol (1985) 1.40
Cepabactin from Pseudomonas cepacia, a new type of siderophore. J Gen Microbiol (1989) 1.40
Nucleotide sequence of the iucD gene of the pColV-K30 aerobactin operon and topology of its product studied with phoA and lacZ gene fusions. J Bacteriol (1988) 1.31
Identification and characterization of the pupB gene encoding an inducible ferric-pseudobactin receptor of Pseudomonas putida WCS358. Mol Microbiol (1993) 1.30
Ornibactins--a new family of siderophores from Pseudomonas. Biometals (1993) 1.30
Siderophore-specific induction of iron uptake in Pseudomonas aeruginosa. J Gen Microbiol (1992) 1.28
Isolation of a novel siderophore from Pseudomonas cepacia. J Med Microbiol (1992) 1.27
Two plasmids, X1918 and Z1918, for easy recovery of the xylE and lacZ reporter genes. Gene (1993) 1.22
Characterisation of the pvdE gene which is required for pyoverdine synthesis in Pseudomonas aeruginosa. Gene (1996) 1.20
Ornibactin production and transport properties in strains of Burkholderia vietnamiensis and Burkholderia cepacia (formerly Pseudomonas cepacia). Biometals (1995) 1.19
Effect of pyochelin on Pseudomonas cepacia respiratory infections. Microb Pathog (1988) 1.18
Identification of alcA, a Bordetella bronchiseptica gene necessary for alcaligin production. Gene (1995) 1.17
Isolation and characterization of Pseudomonas aeruginosa mutants blocked in the synthesis of pyoverdin. J Bacteriol (1992) 1.11
Molecular characterization of rhizosphere and clinical isolates of Burkholderia cepacia. Res Microbiol (1995) 1.11
A cytochrome c biogenesis gene involved in pyoverdine production in Pseudomonas fluorescens ATCC 17400. Mol Microbiol (1996) 1.10
A positive regulatory gene, pvdS, for expression of pyoverdin biosynthetic genes in Pseudomonas aeruginosa PAO. Mol Gen Genet (1995) 1.09
Relationship of iron and extracellular virulence factors to Pseudomonas aeruginosa lung infections. J Med Microbiol (1984) 0.97
Aerosolized prolastin suppresses bacterial proliferation in a model of chronic Pseudomonas aeruginosa lung infection. Am J Respir Crit Care Med (1999) 0.95
The importance of extracellular antigens in Pseudomonas cepacia infections. J Med Microbiol (1988) 0.81
Role of pili in adherence of Pseudomonas aeruginosa to mammalian buccal epithelial cells. Infect Immun (1980) 6.19
Burkholderia thailandensis sp. nov., a Burkholderia pseudomallei-like species. Int J Syst Bacteriol (1998) 5.34
Efflux-mediated aminoglycoside and macrolide resistance in Burkholderia pseudomallei. Antimicrob Agents Chemother (1999) 4.29
A rat model of chronic respiratory infection with Pseudomonas aeruginosa. Am Rev Respir Dis (1979) 4.27
Isolation of cDNA clones for the human complement protein factor B, a class III major histocompatibility complex gene product. Proc Natl Acad Sci U S A (1982) 3.89
Characterization and use of a DNA probe as an epidemiological marker for Pseudomonas aeruginosa. J Infect Dis (1987) 3.79
Mutagenesis of Burkholderia pseudomallei with Tn5-OT182: isolation of motility mutants and molecular characterization of the flagellin structural gene. J Bacteriol (1997) 3.60
Intracellular survival of Burkholderia pseudomallei. Infect Immun (1996) 3.56
Role of fibronectin in the prevention of adherence of Pseudomonas aeruginosa to buccal cells. J Infect Dis (1981) 3.51
Role of adherence in the pathogenesis of Pseudomonas aeruginosa lung infection in cystic fibrosis patients. Infect Immun (1980) 3.23
Epidemiology of sporadic diarrhea due to verocytotoxin-producing Escherichia coli: a two-year prospective study. J Infect Dis (1988) 3.01
Detection of bacterial virulence genes by subtractive hybridization: identification of capsular polysaccharide of Burkholderia pseudomallei as a major virulence determinant. Infect Immun (2001) 2.76
Contribution of toxin A and elastase to virulence of Pseudomonas aeruginosa in chronic lung infections of rats. Infect Immun (1982) 2.76
Effect of rpoS mutation on the stress response and expression of virulence factors in Pseudomonas aeruginosa. J Bacteriol (1999) 2.72
Association of respiratory tract colonization with adherence of gram-negative bacilli to epithelial cells. J Infect Dis (1979) 2.70
Characterization of Burkholderia pseudomallei and Burkholderia pseudomallei-like strains. Epidemiol Infect (1997) 2.69
Sequence of cDNA encoding human insulin-like growth factor I precursor. Nature (1984) 2.69
Identification and population structure of Burkholderia stabilis sp. nov. (formerly Burkholderia cepacia genomovar IV). J Clin Microbiol (2000) 2.63
Disproportionate distribution of Burkholderia cepacia complex species and transmissibility markers in cystic fibrosis. Am J Respir Crit Care Med (2001) 2.55
Identification of a Burkholderia mallei polysaccharide gene cluster by subtractive hybridization and demonstration that the encoded capsule is an essential virulence determinant. Microb Pathog (2001) 2.52
The type II O-antigenic polysaccharide moiety of Burkholderia pseudomallei lipopolysaccharide is required for serum resistance and virulence. Mol Microbiol (1998) 2.46
Burkholderia cenocepacia in cystic fibrosis: epidemiology and molecular mechanisms of virulence. Clin Microbiol Infect (2010) 2.41
Burkholderia ambifaria sp. nov., a novel member of the Burkholderia cepacia complex including biocontrol and cystic fibrosis-related isolates. Int J Syst Evol Microbiol (2001) 2.27
Molecular map of the murine S region. Proc Natl Acad Sci U S A (1983) 2.24
Characterization of Pseudomonas cepacia isolates from patients with cystic fibrosis. J Clin Microbiol (1984) 2.23
Phenotypic methods for determining genomovar status of the Burkholderia cepacia complex. J Clin Microbiol (2001) 2.06
Enhanced gene replacement in mycobacteria. Microbiology (1999) 1.91
Regulation of the inducible acetamidase gene of Mycobacterium smegmatis. Microbiology (1997) 1.86
Use of a cDNA clone for the fourth component of human complement (C4) for analysis of a genetic deficiency of C4 in guinea pig. Proc Natl Acad Sci U S A (1983) 1.82
Demonstration of an iron-siderophore-binding protein in the outer membrane of Pseudomonas aeruginosa. Infect Immun (1983) 1.82
Toxins of Pseudomonas aeruginosa: new perspectives. Rev Infect Dis (1983) 1.77
Isolation and characterization of Pseudomonas pseudomallei flagellin proteins. Infect Immun (1994) 1.77
Broad-host-range cloning and cassette vectors based on the R388 trimethoprim resistance gene. Biotechniques (1996) 1.70
Structural and immunological characterization of Burkholderia pseudomallei O-polysaccharide-flagellin protein conjugates. Infect Immun (1996) 1.70
Purification and characterization of an extracellular protease from Pseudomonas cepacia. Infect Immun (1989) 1.70
Inhibition of Pseudomonas aeruginosa exoenzyme expression by subinhibitory antibiotic concentrations. Antimicrob Agents Chemother (1989) 1.69
Beta-cell dysfunction, rather than insulin insensitivity, is the primary defect in familial type 2 diabetes. Lancet (1986) 1.61
Phenotypic comparison of Pseudomonas aeruginosa strains isolated from a variety of clinical sites. J Clin Microbiol (1986) 1.60
The CepIR quorum-sensing system contributes to the virulence of Burkholderia cenocepacia respiratory infections. Microbiology (2003) 1.55
Clostridium sordellii infection and toxin neutralization. Pediatr Infect Dis J (1990) 1.53
Ribotype analysis of Pseudomonas pseudomallei isolates. J Clin Microbiol (1993) 1.52
Burkholderia cepacia complex infection in Italian patients with cystic fibrosis: prevalence, epidemiology, and genomovar status. J Clin Microbiol (2001) 1.50
Complete primary structure for the zymogen of human complement factor B. J Biol Chem (1984) 1.48
Continuous infusion of glucose with model assessment: measurement of insulin resistance and beta-cell function in man. Diabetologia (1985) 1.44
Role of salivary protease activity in adherence of gram-negative bacilli to mammalian buccal epithelial cells in vivo. J Clin Invest (1981) 1.40
Passive protection of diabetic rats with antisera specific for the polysaccharide portion of the lipopolysaccharide isolated from Pseudomonas pseudomallei. Can J Infect Dis (1994) 1.38
Pathogenesis of and immunity to melioidosis. Acta Trop (2000) 1.38
Burkholderia cepacia in cystic fibrosis. Variable disease course. Am J Respir Crit Care Med (1999) 1.35
Pseudomonas aeruginosa exoenzyme S is an adhesion. Infect Immun (1991) 1.30
Molecular characterization of genetic loci required for secretion of exoproducts in Burkholderia pseudomallei. J Bacteriol (1999) 1.29
Bacterial adherence to epithelial cells in bacillary colonization of the respiratory tract. Am Rev Respir Dis (1980) 1.28
Purification of Pseudomonas aeruginosa exoenzyme S. Infect Immun (1987) 1.28
Syrian hamster female protein: analysis of female protein primary structure and gene expression. Science (1985) 1.28
An extracellular zinc metalloprotease gene of Burkholderia cepacia. Microbiology (2003) 1.27
Molecular epidemiology of Proteus mirabilis infections of the catheterized urinary tract. J Clin Microbiol (2003) 1.25
Production of lipase by clinical isolates of Pseudomonas cepacia. J Clin Microbiol (1988) 1.25
Isolation of polymyxin B-susceptible mutants of Burkholderia pseudomallei and molecular characterization of genetic loci involved in polymyxin B resistance. Antimicrob Agents Chemother (1999) 1.25
Phylogenetic conservation of a class III major histocompatibility complex antigen, factor B. Isolation and nucleotide sequencing of mouse factor B cDNA clones. J Biol Chem (1983) 1.23
Studies on the ability of alginate to act as a protective immunogen against infection with Pseudomonas aeruginosa in animals. J Infect Dis (1985) 1.23
Burkholderia cepacia complex genomovars and pulmonary transplantation outcomes in patients with cystic fibrosis. Lancet (2001) 1.20
DNA polymorphism of the C4 genes. A new marker for analysis of the major histocompatibility complex. N Engl J Med (1984) 1.19
Mycobacterium tuberculosis efpA encodes an efflux protein of the QacA transporter family. Clin Diagn Lab Immunol (1997) 1.19
Effect of pyochelin on Pseudomonas cepacia respiratory infections. Microb Pathog (1988) 1.18
Human ultralente insulin. Br Med J (Clin Res Ed) (1984) 1.14
Identification and characterization of a two-component regulatory system involved in invasion of eukaryotic cells and heavy-metal resistance in Burkholderia pseudomallei. Infect Immun (1997) 1.14
Characterization of antibody to the ferripyochelin-binding protein of Pseudomonas aeruginosa. Infect Immun (1986) 1.13
Isolation of a complementary DNA clone for the human complement protein C2 and its use in the identification of a restriction fragment length polymorphism. J Clin Invest (1984) 1.13
Three-year outbreak of pseudobacteremia with Burkholderia cepacia traced to a contaminated blood gas analyzer. Infect Control Hosp Epidemiol (1996) 1.12
PCR-based detection and identification of Burkholderia cepacia complex pathogens in sputum from cystic fibrosis patients. J Clin Microbiol (2001) 1.10
Use of transposon mutants to assess the role of exoenzyme S in chronic pulmonary disease due to Pseudomonas aeruginosa. Eur J Clin Microbiol (1985) 1.07
Purification and characterization of a protease from Pseudomonas pseudomallei. Can J Microbiol (1994) 1.07
Evaluation of random amplified polymorphic DNA typing of Pseudomonas aeruginosa. J Clin Microbiol (2000) 1.05
Role of swarming in the formation of crystalline Proteus mirabilis biofilms on urinary catheters. J Med Microbiol (2005) 1.05
Biotechnological potential within the genus Burkholderia. Lett Appl Microbiol (2005) 1.03
Isolation of human C-reactive protein complementary DNA and localization of the gene to chromosome 1. Science (1983) 1.02
Lung bacterial clearance in murine pneumococcal pneumonia. Infect Immun (1977) 1.01
Antilipopolysaccharide II: an antibody protective against fatal melioidosis. Clin Infect Dis (1999) 1.01
Subinhibitory antibiotics reduce Pseudomonas aeruginosa tissue injury in the rat lung model. J Antimicrob Chemother (1989) 1.00
Isolation and characterization of the outer-membrane proteins of Burkholderia (Pseudomonas) pseudomallei. Microbiology (1994) 1.00
Immunization with a Pseudomonas aeruginosa elastase peptide reduces severity of experimental lung infections due to P. aeruginosa Or Burkholderia cepacia. J Infect Dis (2000) 1.00
Protection by antibiotics against myeloperoxidase-dependent cytotoxicity to lung epithelial cells in vitro. J Clin Invest (1993) 1.00
Identification of a siderophore receptor required for ferric ornibactin uptake in Burkholderia cepacia. Infect Immun (2000) 0.99
The isolation and characterization of cDNA clones for human apolipoprotein CII. J Biol Chem (1984) 0.98
Relationship of iron and extracellular virulence factors to Pseudomonas aeruginosa lung infections. J Med Microbiol (1984) 0.97
Neutralizing monoclonal antibodies to an extracellular Pseudomonas cepacia protease. Infect Immun (1994) 0.97
Biosynthesis and postsynthetic processing of human C-reactive protein. J Immunol (1983) 0.97
Immunological cross-reactivity of a Mycoplasma pneumoniae membrane-associated protein antigen with Mycoplasma genitalium and Acholeplasma laidlawii. J Clin Microbiol (1987) 0.97
Partial reversal of established bleomycin-induced pulmonary fibrosis by rh-urokinase in a rat model. Clin Invest Med (1994) 0.97
Antibody inhibition of ferripyochelin binding to Pseudomonas aeruginosa cell envelopes. Biochemistry (1984) 0.97
Isolation and sequence analysis of a cDNA clone encoding the fifth complement component. J Biol Chem (1985) 0.96
Monoclonal antibodies to Pseudomonas aeruginosa ferripyochelin-binding protein. Infect Immun (1986) 0.95
Aerosolized prolastin suppresses bacterial proliferation in a model of chronic Pseudomonas aeruginosa lung infection. Am J Respir Crit Care Med (1999) 0.95
Elevated exoenzyme expression by Pseudomonas aeruginosa is correlated with exacerbations of lung disease in cystic fibrosis. Pediatr Pulmonol (1993) 0.94
Cloning and expression of the Pseudomonas aeruginosa exoenzyme S toxin gene. Microb Pathog (1990) 0.94
Pseudomonas aeruginosa exoenzyme S induces proliferation of human T lymphocytes. Infect Immun (1995) 0.93